400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2200065390
尚未开始
/
/
/
2022-11-03
/
/
Substance abuse
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
To evaluate the effectiveness of a brief individual mindfulness training when added to smoking cessation treatment (i.e. nicotine replacement therapy + counseling) for preventing relapse in smoking compared to smoking cessation treatment only. Previous meta-analyses suggested having a more vigorous design in research on mindfulness training for smoking cessation (Maglione et al., 2017; Oikonomou et al., 2017). This study will be reported following the Consolidated Standards of Reporting Trials (CONSORT) standards (Schulz et al., 2010).
随机平行对照
Ⅰ期
The randomization table of each strata will be generated by an independent researcher via an online software.
none
未说明
/
45
/
2022-10-03
2024-10-03
/
1. Self-report daily smokers; 2. Receive nicotine patch treatment; 3. Motivated to quit within the next 30 days; 4. Aged >= 18 years; 5. Able to speak and read Chinese; 6. Not being pregnant.；
请登录查看1. Contraindication of nicotine patch use; 2. With significant physical illness or severe cognitive impairment that create obstacle for communication, such as blindness or severe hearing loss; 3. Actively psychotic or manic; 4. With active illicit drug use; 5. Alcohol dependence with Alcohol Use Disorders Identification Test (AUDIT) score 20 or above (World-Health-Organization, 2001); 6. Participation in mindfulness course or having daily mindfulness practice in the previous 12 months; 7. Participation in smoking cessation treatment in the previous 12 months.；
请登录查看Prince of Wales Hospital
/
德琪医药2026-07-20
动脉网-最新2026-07-20
药精通Bio2026-07-20
求实药社2026-07-20
求实药社2026-07-20
康方生物Akeso2026-07-20
干细胞与外泌体2026-07-20
加科思2026-07-20
良医汇肿瘤资讯2026-07-19
GLP1减重宝典2026-07-19
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
